Evogene Schedules Third Quarter 2024 Financial Results Release
Evogene (Nasdaq: EVGN, TASE: EVGN), a computational biology company, announced the release of its Q3 2024 financial results on November 21, 2024. The company's management will discuss the results in a Zoom conference call scheduled for the same day at 9:00 AM ET (4:00 PM Israel time). To attend, participants need to register in advance. The conference will be available online on Evogene's website a few days after the event.
Evogene (Nasdaq: EVGN, TASE: EVGN), un'azienda di biologia computazionale, ha annunciato il rilascio dei risultati finanziari per il terzo trimestre del 2024 il 21 novembre 2024. La direzione dell'azienda discuterà i risultati in una conferenza Zoom programmata per lo stesso giorno alle 9:00 AM ET (16:00 ora israeliana). Per partecipare, i partecipanti devono registrarsi in anticipo. La conferenza sarà disponibile online sul sito web di Evogene pochi giorni dopo l'evento.
Evogene (Nasdaq: EVGN, TASE: EVGN), una empresa de biología computacional, anunció la publicación de sus resultados financieros del tercer trimestre de 2024 el 21 de noviembre de 2024. La dirección de la empresa discutirá los resultados en una llamada de conferencia por Zoom programada para el mismo día a las 9:00 AM ET (4:00 PM hora de Israel). Para asistir, los participantes deben registrarse con anticipación. La conferencia estará disponible en línea en el sitio web de Evogene unos días después del evento.
Evogene (Nasdaq: EVGN, TASE: EVGN), 컴퓨터 생물학 회사,는 2024년 11월 21일에 2024년 3분기 재무 결과를 발표했습니다. 회사 경영진은 같은 날 오전 9시(이스라엘 시간 오후 4시)에 예정된 Zoom 회의에서 결과에 대해 논의할 것입니다. 참석하려면 사전 등록이 필요합니다. 회의는 이벤트 후 며칠 내에 Evogene 웹사이트에서 온라인으로 제공됩니다.
Evogene (Nasdaq: EVGN, TASE: EVGN), une entreprise de biologie computationnelle, a annoncé la publication de ses résultats financiers pour le troisième trimestre 2024 le 21 novembre 2024. La direction de l'entreprise discutera des résultats lors d'une conférence Zoom prévue le même jour à 9h00 ET (16h00 heure d'Israël). Pour assister, les participants doivent s'inscrire à l'avance. La conférence sera disponible en ligne sur le site Web d'Evogene quelques jours après l'événement.
Evogene (Nasdaq: EVGN, TASE: EVGN), ein Unternehmen für computergestützte Biologie, gab die Veröffentlichung seiner Finanzberichte für das dritte Quartal 2024 am 21. November 2024 bekannt. Die Geschäftsführung des Unternehmens wird die Ergebnisse in einer Zoom-Konferenz am selben Tag um 9:00 Uhr ET (16:00 Uhr israelischer Zeit) erörtern. Um teilzunehmen, müssen sich die Teilnehmer im Voraus registrieren. Die Konferenz wird einige Tage nach der Veranstaltung auf der Website von Evogene online verfügbar sein.
- Evogene has scheduled a timely release of its Q3 2024 financial results, demonstrating transparency and commitment to keeping shareholders informed.
- None.
Zoom conference call scheduled for November 21, 2024, 9:00 AM ET
REHOVOT,
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).
To join the conference, please register in advance:
https://us06web.zoom.us/webinar/register/WN_pG-Wc0JeQIifu1dmSUYOng
The entire conference will be available online on the company's website a few days after.
About Evogene:
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:
- Biomica Ltd. (www.biomicamed.com) - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
- Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
- AgPlenus Ltd. (www.agplenus.com) - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
- Casterra Ag Ltd. (www.casterra.co) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.
For more information, please visit: www.evogene.com.
Logo - https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg
Contact
ir@evogene.com
Tel: +972-8-9311901
View original content:https://www.prnewswire.com/news-releases/evogene-schedules-third-quarter-2024-financial-results-release-302298582.html
SOURCE Evogene
FAQ
When will Evogene release its Q3 2024 financial results?
What time is Evogene's Q3 2024 financial results conference call?
How can I join Evogene's Q3 2024 financial results conference call?
Where can I access the recording of Evogene's Q3 2024 financial results conference call?
